http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202100180-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c00f13e338e8dc36579ece14574d71ab |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate | 2020-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_116ed7dba2e34a7bee9c14473cbdd6c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80a24ef069fb798fc08867d3a348d503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_829133ba8ce1fcc0d72124c7caf28611 |
| publicationDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-202100180-A |
| titleOfInvention | Manufacturing method of influenza HA split vaccine |
| abstract | The present invention provides a method for manufacturing a split influenza HA vaccine, which produces antibodies that bind to the stem region of influenza HA that is not prone to cause antigenic variation. Apply acid treatment to influenza HA split vaccine. The influenza HA split vaccine obtained by acid treatment produces antibodies that bind to LAH in the HA stem region. The influenza HA split vaccine has excellent defense capabilities against other influenza virus infections with different antigenic properties. |
| priorityDate | 2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 207.